Literature DB >> 31602291

Pancreatogastrostomy vs pancreatojejunostomy after pancreaticoduodenectomy: An updated meta-analysis of RCTs and our experience.

Yun Jin1, Yang-Yang Feng1, Xiao-Gang Qi1, Geng Hao1, Yuan-Quan Yu1, Jiang-Tao Li1, Shu-You Peng1.   

Abstract

BACKGROUND: Pancreatoduodenectomy (PD) is one of the most important operations in hepatobiliary and pancreatic surgery. AIM: To evaluate the advantages and disadvantages of pancreaticojejunostomy (PJ) and pancreaticogastrostomy (PG).
METHODS: This meta-analysis was performed using Review Manager 5.3. All clinical randomized controlled trials, in which patients underwent PD with pancreatico-digestive tract reconstruction via PJ or PG, were included.
RESULTS: The search of PubMed, Wanfang Data, EMBASE, and the Cochrane Library provided 125 citations. After further analysis, 11 trials were included from nine counties. In all, 909 patients underwent PG and 856 underwent PJ. Meta-analysis showed that pancreatic fistula (PF) was a significantly lower morbidity in the PG group than in the PJ group (odds ratio [OR] = 0.67, 95% confidence interval [CI]: 0.53-0.86, P = 0.002); however, grades B and C PF was not significantly different between the two groups (OR = 0.61, 95%CI: 0.34-1.09, P = 0.09). Postoperative hemorrhage showed a significantly lower morbidity in the PJ group than in the PG group (OR = 1.47, 95%CI: 1.05-2.06, P = 0.03). Delayed gastric emptying was not significantly different between the two groups (OR = 1.09, 95%CI: 0.83-1.41, P = 0.54).
CONCLUSION: There is no difference in the incidence of grades B and C PF between the two groups. However, postoperative bleeding is significantly higher in PG than in PJ. Binding PJ or binding PG is a safe and secure technique according to our decades of experience. ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Meta-analysis; Pancreaticogastrostomy; Pancreaticojejunostomy; Systematic review

Year:  2019        PMID: 31602291      PMCID: PMC6783689          DOI: 10.4240/wjgs.v11.i7.322

Source DB:  PubMed          Journal:  World J Gastrointest Surg


Core tip: Pancreatico-digestive tract anastomosis after pancreaticoduodenectomy is still controversial. This systematic review and meta-analysis aimed to further evaluate the role and importance of pancreaticojejunostomy and pancreaticogastrostomy. We compared the complications of these two surgical procedures, including pancreatic fistula, delayed gastric emptying, and hemorrhage.

INTRODUCTION

Pancreatoduodenectomy (PD) is the main treatment procedure for benign and malignant tumors of the pancreatic head, lower common bile duct, and ampulla[1]. The incidence of complications after PD is still high, with some large pancreatic centers reporting an incidence of approximately 10-45%[2-7]. The incidence of pancreatic fistula (PF), delayed gastric emptying (DGE), and gastrointestinal or abdominal hemorrhage has been reported to be 3-45%[8], 5%-61%[9,10], and 1%-8%[11], respectively. Other complications include abdominal empyema, incision infection, and pulmonary infection[12]. Since the establishment of PD, pancreatico-digestive tract reconstruction has been a highly valued research area, which is considered to be closely related to the success /failure of the surgery[13]. In general, pancreatico-digestive tract reconstruction includes pancreaticojejunostomy (PJ) and pancreaticogastrostomy (PG). Unlike gastrointestinal anastomosis, these two types of reconstruction after pancreatic surgery are diverse, with different results and evaluations. Therefore, there is still room for improvement in PJ and PG, and these procedures are still the focus of future research in PD. This systematic review and meta-analysis aimed to further evaluate the role and importance of pancreatico-digestive tract anastomosis. Further, the advantages and disadvantages of PJ and PG were compared to provide a valuable reference for a more reasonable and safe choice of pancreatico-digestive tract reconstruction in the future.

MATERIALS AND METHODS

Eligibility criteria

All clinical randomized controlled trials, in which patients underwent PD with pancreatico-digestive tract reconstruction via PJ or PG, were included.

Information sources

Studies were identified by searching electronic databases and scanning reference lists of articles. No limits were applied for languages and foreign papers were translated to English. The search was applied to Medline, Wanfang Data, EMBASE, Science Citation Index Expanded, and the Cochrane Library. The last search was run on March 15, 2019.

Search

We used the following search terms to search all trial registers and databases: Pan-creatoduodenectomy or Pancreatoduodenectomies or Duodenopancreatectomy or Duodenopancreatectomies or Pancreaticoduodenectomy or Whipple or PD or Whipple procedure or Pancreatoduodenal resection or Pancreaticoduodenal resection, Pancreaticojejunostomy or Pancreaticojejunostomies or Pancreatojejunostomy or Pancreatojejunostomies or Pancreaticoenteric anastomosis or Pancreatoenteric anastomosis or Pancreaticojejunal anastomosis or Pancreatojejunal anastomosis or PJ, or Pancreaticogastrostomy or PG.

Study selection

Eligibility assessment was performed independently in an unblinded standardized manner by two reviewers. Disagreements between reviewers were resolved by discu-ssion.

Data collection process

One review author extracted the following data from the included studies and the second author checked the extracted data. Disagreements were resolved by discussion between the two review authors; if no agreement could be reached, a third author would take the decision.

Data items

Data were extracted from each included trial on: (1) Characteristics of trial participants including age, disease, and number of patients; (2) Intervention with PG vs PJ; (3) Type of outcome measures including the definition and occurrence of PF, DGE, and other postoperative complications.

Risk of bias in individual studies

To ascertain the validity of eligible randomized trials, two independent reviewers with adequate reliability determined the adequacy of randomization, concealment of allocation, blinding of patients, healthcare providers, data collectors, and outcome assessors.

Statistical analysis

The meta-analysis was performed using Review Manager 5.3. The Chi-square test was used to test heterogeneity among studies. The heterogeneity level was judged accor-ding to I2. Relative risk (RR), weighted mean difference (WMD), standardized mean difference (SMD), and 95%CI (confidence interval) were used. For data with clinical heterogeneity, it is not easy to merge effect quantities. First, we tested heterogeneity among studies. Then subgroup analysis or meta-regression analysis was conducted according to heterogeneity. If data were insufficient or heterogeneity cannot be found, a random-effects model was used. The homogeneity of data was tested by the χ2 test, and the homogeneity was quantitatively analyzed by the I2 test. If there was no statistical heterogeneity, a fixed-effects model was used. When statistical analysis showed heterogeneity, a random-effects model was used. The significance level of the hypothesis test was set at P < 0.05. To assess the risk of bias across studies, we plotted the effect by the inverse of its standard error for each trial. The symmetry was assessed both visually, and formally by the Egger's test.

RESULTS

A total of 11 studies involving 11 trials were identified for inclusion in the review[14-24]. The search of PubMed, Wanfang Data, Embase, and the Cochrane Library provided 125 citations. Of the total 125 citations, 29 studies were discarded because they did not meet the inclusion criteria. Nine additional studies were discarded because full texts for these were not available. The full texts of the remaining 65 citations were exam-ined in further detail. Following this, 51 studies were found not to meet the inclusion criteria as described, and three were repeat studies from the same institute at different time points (we chose the latest study in this case). Finally, 11 studies met the inclusion criteria and were included in the systematic review. Figure 1 shows the flow diagram of study selection (Figure 1).
Figure 1

Study flow diagram.

Study flow diagram. From 1995 to 2016, 11 trials were included from nine counties. In all, 909 patients underwent PG and 856 underwent PJ. PF was defined and classified following the International Study Group on Pancreatic Fistula (ISGPF) consensus guidelines in seven trials[15,17-22] (Table 1). The quality of these 11 trials is presented in Figure 2.
Table 1

Characteristic of included trials

AuthorYearCountryStudy typeNumber of PGNumber of PJDefinition of PF
Yeo et al[14]1995United StatesSingle blind, controlled randomized, single center trial7372PF was defined as drainage of greater than 50 mL of amylase-rid fluid on or after postoperative day 10
Duffas et al[23]2005FranceSingle blind, controlled randomized, multicenter trial8168Fluid obtained through drains or percutaneous aspiration, containing at least 4 times normal serum values of amylase for 3 day
Bassi et al[25]2005ItalySingle blind, controlled randomized, single center trial6982Any clinically significant output of fluid, rich in amylase, confirmed by fistulography
Bassi et al[8]2008SpainSingle blind, controlled randomized, single center trial5355ISGPF definition
Wellner et al[15]2012GermanySingle blind, controlled randomized, single center trial5957ISGPF definition
Wang et al[30]2012ChinaSingle blind, controlled randomized, multicenter trial8353ISGPF definition
El Nakeeb et al[20]2013EgyptSingle blind, controlled randomized, single center trial4545ISGPF definition
Topal et al[18]2013BelgiumSingle blind, controlled randomized, multicenter trial162167ISGPF definition
Figueras et al[22]2013SpainSingle blind, controlled randomized, multicenter trial6558ISGPF definition
Grendar et al[24]2015CanadaSingle blind, controlled randomized, single center trial4850Either radiologically proven anastomotic leak or continued drainage (via drain, enterocutaneous fistula, or wound) of lipase­rich fluid on postoperative day 10
Keck et al[19]2016GermanySingle blind, controlled randomized, multicenter trial171149ISGPF definition

PG: Pancreaticogastrostomy; PJ: Pancreaticojejunostomy; PF: Postoperative pancreatic fistula.

Figure 2

Quality of the included trials.

Characteristic of included trials PG: Pancreaticogastrostomy; PJ: Pancreaticojejunostomy; PF: Postoperative pancreatic fistula. Quality of the included trials. PF data were available for all 11 trials randomizing 1765 patients and reporting data for them. In the meta-analysis, there was no significant hetero-geneity between these studies (I2 = 20%); therefore, a fixed-effects model was applied. PF showed a significantly lower morbidity in the PG group than in the PJ group (odds ratio [OR] = 0.67, 95%CI: 0.53-0.86, P = 0.002) (Figure 3). Grade A PF did not affect the disease outcome; therefore, we further analyzed the incidence of grades B and C PF. Seven trials with 603 PG and 581 PJ patients were included. In the meta-analysis, there was a significant difference in heterogeneity between these studies (I2 = 61%); accordingly, a random-effects model was applied. Grades B and C PF was not significantly different between the two groups (OR = 0.61, 95%CI: 0.34-1.09, P = 0.09) (Figure 4).
Figure 3

Forest plot of the incidence of all grades of postoperative pancreatic fistula. PG: Pancreaticogastrostomy; PJ: Pancreaticojejunostomy; PF: Postoperative pancreatic fistula.

Figure 4

Forest plot of the incidence of grade B/C postoperative pancreatic fistula. PG: Pancreaticogastrostomy; PJ: Pancreaticojejunostomy; PF: Postoperative pancreatic fistula.

Forest plot of the incidence of all grades of postoperative pancreatic fistula. PG: Pancreaticogastrostomy; PJ: Pancreaticojejunostomy; PF: Postoperative pancreatic fistula. Forest plot of the incidence of grade B/C postoperative pancreatic fistula. PG: Pancreaticogastrostomy; PJ: Pancreaticojejunostomy; PF: Postoperative pancreatic fistula. Nine trials with 788 PG and 734 PJ patients were included for analyzing postoperative hemorrhage. In the meta-analysis, there was no significant hetero-geneity between these studies (I2 = 0%); accordingly, a fixed-effects model was applied. Postoperative hemorrhage showed a significantly lower morbidity in the PJ group than in the PG group (OR = 1.47, 95%CI: 1.05-2.06, P = 0.03) (Figure 5).
Figure 5

Forest plot of the incidence of postoperative hemorrhage. PG: Pancreaticogastrostomy; PJ: Pancreaticojejunostomy.

Forest plot of the incidence of postoperative hemorrhage. PG: Pancreaticogastrostomy; PJ: Pancreaticojejunostomy. Nine trials including 780 PG and 738 PJ patients were included for the analysis of DGE. In the meta-analysis, there was no significant heterogeneity between these studies (I2 = 47%), and therefore a fixed-effects model was applied. DGE was not significantly different between the two groups (OR = 1.09, 95%CI: 0.83-1.41, P = 0.54) (Figure 6).
Figure 6

Forest plot of the incidence of delayed gastric emptying. PG: Pancreaticogastrostomy; PJ: Pancreaticojejunostomy; PF: Postoperative pancreatic fistula.

Forest plot of the incidence of delayed gastric emptying. PG: Pancreaticogastrostomy; PJ: Pancreaticojejunostomy; PF: Postoperative pancreatic fistula.

DISCUSSION

PF is one of the most common complications after PD. PF not only causes serious complications such as abdominal bleeding but also increases the length of hospital stay and cost for patients. Our study showed that PG anastomosis can reduce the incidence of all grades of PF than PJ anastomosis. In 2005, the ISGPF defined PF and divided it into three levels[25]. In 2016, the group adjusted the classification of PF and defined grade A PF as a biochemical fistula[8]. Therefore, in this study, we considered the incidence of grades B/C PF in subgroup analysis. We believe that this statistical analysis has more clinical value and significance. We found no statistical difference in grades B/C PF between the two groups (PJ and PG). However, our result showed that PG anastomosis may increase the incidence of bleeding compared with PJ anasto-mosis. Our group has studied the anastomosis of the pancreas and digestive tract for more than 20 years, and has accumulated some experiences[7,26,27]. In 1996, we established the binding pancreaticojejunostomy (BPJ). The main feature of this surgery is that the anastomosis between the jejunum and pancreas is mainly made with a binding line. It avoids the needle hole penetrating the intestinal cavity on the surface of the anastomotic site, thus preventing the leakage of pancreatic juice from the pinholes, to fundamentally eliminate the possibility of PF. At present, BPJ has been applied in more than a thousand of cases, which has a significant effect on the prevention of PF after surgery[7]. In 2010, Buc, a French scholar, named BPJ procedure as Peng's PJ and reported that BPJ was a safe and secure technique[28]. In 2008, Peng created the binding pancreaticogastrostomy (BPG), which simplified the operation steps of the previous pancreas-stomach anastomosis[29]. After continuous improvement, only the bundled method was used in the posterior wall of the stomach, avoiding the suture of pancreas parenchyma and thus greatly shortening the surgical time and preventing anasto-motic leakage. BPG not only solves the problem of excessive pancreatic stump but also reduces the harm of bile leakage because the biliary-enteric anastomosis is not in the same channel as PG anastomosis[27]. The mid-term results of the randomized controlled study showed that the incidence of PF in BPG and BPJ was acceptable[17]. In recent years, with the continuous development of laparoscopic technology, laparoscopic PD has gradually become an alternative method, used as a routine treatment in some pancreatic surgeries[30-32]. Thus, laparoscopic pancreatico-gastrointestinal anastomosis has become a new focus for research. Owing to the limitation of the laparoscopic visual field, pancreatic duct to mucosa anastomosis is the first choice of procedure under laparoscopy[30]. The attempt of various methods makes the technique of PJ dazzling. However, the basic content cannot be separated from pancreas-jejunum (stomach) anastomosis or pancreatic duct-jejunum (stomach) anastomosis. The objective of evaluation should be as simple as possible. Moreover, the lower the incidence of pancreatic leakage compared with classical anastomosis, the better. As long as these principles are followed, sample enlargement and randomized controlled trials should be conducted to find the best method.

ARTICLE HIGHLIGHTS

Research background

Pancreatoduodenectomy (PD) is one of the most important operations in hepatobiliary and pancreatic surgery. Pancreatico-digestive tract reconstruction includes pancreaticojejunostomy (PJ) and pancreaticogastrostomy (PG). Unlike gastrointestinal anastomosis, these two types of reconstruction after pancreatic surgery are diverse, with different results and evaluations. Therefore, there is still room for improvement in PJ and PG, and these procedures are still the focus of future research in PD.

Research motivation and objectives

This systematic and meta-analysis aimed to evaluate the role and importance of pancreatico-digestive tract anastomosis. Advantages and disadvantages of PJ and PG were compared to provide a valuable reference and safe choice in the future.

Research methods

This search was applied to Medline, Wanfang Data, Embase, Science Citation Index Expanded, and the Cochrane Library. The last search was run on March 15, 2019. All clinical randomized controlled trials, in which patients underwent PD with pancreatico-digestive tract reconstruction via PJ or PG, were included. The Chi-square test was used to test heterogeneity among studies. The heterogeneity level was judged according to I. Relative risk (RR), weighted mean difference (WMD), standardized mean difference (SMD), and 95%CI were used.

Research results

In the meta-analysis of postoperative hemorrhage, there was no significant heterogeneity between these studies (I2 = 0%); accordingly, a fixed-effect model was applied. Postoperative hemorrhage showed a significantly lower morbidity in the PJ group than in the PG group (OR = 1.47, 95%CI: 1.05-2.06, P = 0.03). In the meta-analysis of DGE, there was no significant heterogeneity between these studies (I2 = 47%), and therefore a fixed-effects model was applied. DGE was not significantly different between the two groups (OR = 1.09, 95%CI: 0.83-1.41, P = 0.54).

Research conclusions

Our group has studied the anastomosis of the pancreas and digestive tract for more than 20 years, and has accumulated some experiences. We established the binding pancreaticoje-junostomy (BPJ) and binding pancreaticogastrostomy (BPG). The mid-term results of the randomized controlled study showed that the incidence of PF in BPG and BPJ was acceptable.

Research perspectives

Laparoscopic pancreaticogastrointestinal anastomosis has become a new focus for research. The objective of evaluation should be as simple as possible. Moreover, the lower the incidence of pancreatic leakage compared with classical anastomosis, the better. As long as these principles are followed, sample enlargement and randomized controlled trials should be conducted to find the best method.
  31 in total

1.  Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS).

Authors:  Moritz N Wente; Claudio Bassi; Christos Dervenis; Abe Fingerhut; Dirk J Gouma; Jakob R Izbicki; John P Neoptolemos; Robert T Padbury; Michael G Sarr; L William Traverso; Charles J Yeo; Markus W Büchler
Journal:  Surgery       Date:  2007-11       Impact factor: 3.982

Review 2.  The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After.

Authors:  Claudio Bassi; Giovanni Marchegiani; Christos Dervenis; Micheal Sarr; Mohammad Abu Hilal; Mustapha Adham; Peter Allen; Roland Andersson; Horacio J Asbun; Marc G Besselink; Kevin Conlon; Marco Del Chiaro; Massimo Falconi; Laureano Fernandez-Cruz; Carlos Fernandez-Del Castillo; Abe Fingerhut; Helmut Friess; Dirk J Gouma; Thilo Hackert; Jakob Izbicki; Keith D Lillemoe; John P Neoptolemos; Attila Olah; Richard Schulick; Shailesh V Shrikhande; Tadahiro Takada; Kyoichi Takaori; William Traverso; Charles R Vollmer; Christopher L Wolfgang; Charles J Yeo; Roberto Salvia; Marcus Buchler
Journal:  Surgery       Date:  2016-12-28       Impact factor: 3.982

3.  [Binding pancreaticogastrostomy].

Authors:  Shu-you Peng; De-fei Hong; Ying-bin Liu; Zhi-jian Tan; Jiang-tao Li; Feng Tao
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2009-01-15

Review 4.  Minimally invasive pancreatoduodenectomy.

Authors:  Michael L Kendrick; Jony van Hilst; Ugo Boggi; Thijs de Rooij; R Matthew Walsh; Herbert J Zeh; Steven J Hughes; Yoshiharu Nakamura; Charles M Vollmer; David A Kooby; Horacio J Asbun
Journal:  HPB (Oxford)       Date:  2017-03       Impact factor: 3.647

5.  Practice Patterns and Perioperative Outcomes of Laparoscopic Pancreaticoduodenectomy in China: A Retrospective Multicenter Analysis of 1029 Patients.

Authors:  Min Wang; Bing Peng; Jianhua Liu; Xinmin Yin; Zhijian Tan; Rong Liu; Defei Hong; Wenxing Zhao; Heshui Wu; Rufu Chen; Dewei Li; Heguang Huang; Yi Miao; Yahui Liu; Tingbo Liang; Wei Wang; Yunqiang Cai; Zhongqiang Xing; Wei Cheng; Xiaosheng Zhong; Zhiming Zhao; Jungang Zhang; Zhiyong Yang; Guolin Li; Yue Shao; Guirong Lin; Kuirong Jiang; Pengfei Wu; Baoxing Jia; Tao Ma; Chongyi Jiang; Shuyou Peng; Renyi Qin
Journal:  Ann Surg       Date:  2021-01-01       Impact factor: 12.969

6.  Technical aspects of pancreaticoduodenectomy and their outcomes.

Authors:  Katherine Giuliano; Aslam Ejaz; Jin He
Journal:  Chin Clin Oncol       Date:  2017-09-26

7.  Peng's binding pancreaticojejunostomy after pancreaticoduodenectomy: a French prospective study.

Authors:  Emmanuel Buc; Renaud Flamein; Claudio Golffier; Anne Dubois; Ganesh Nagarajan; Emmanuel Futier; Denis Pezet
Journal:  J Gastrointest Surg       Date:  2010-04       Impact factor: 3.452

8.  Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy for pancreatic or periampullary tumours: a multicentre randomised trial.

Authors:  Baki Topal; Steffen Fieuws; Raymond Aerts; Joseph Weerts; Tom Feryn; Geert Roeyen; Claude Bertrand; Catherine Hubert; Marc Janssens; Jean Closset
Journal:  Lancet Oncol       Date:  2013-05-02       Impact factor: 41.316

9.  Prognostic factors for survival and surgical complications in Whipple's pancreatoduodenectomy during a 10-year experience.

Authors:  Francisco Reyna-Sepúlveda; Gerardo Muñoz-Maldonado; Edelmiro Pérez-Rodríguez; Fabiola Hernández-Trejo; Asdruval Guevara-Charles; Marco Hernández-Guedea
Journal:  Cir Cir       Date:  2019       Impact factor: 0.361

10.  Early reoperation following pancreaticoduodenectomy: impact on morbidity, mortality, and long-term survival.

Authors:  Yonatan Lessing; Niv Pencovich; Nadav Nevo; Nir Lubezky; Yaacov Goykhman; Richard Nakache; Guy Lahat; Joseph M Klausner; Ido Nachmany
Journal:  World J Surg Oncol       Date:  2019-01-31       Impact factor: 2.754

View more
  4 in total

1.  Double purse-string telescoped pancreaticogastrostomy is not superior in preventing pancreatic fistula development in high-risk anastomosis: a 6-year single-center case-control study.

Authors:  Jonathan Garnier; Jacques Ewald; Ugo Marchese; Anais Palen; Djamel Mokart; Gilles Piana; Jean-Robert Delpero; Olivier Turrini
Journal:  Langenbecks Arch Surg       Date:  2021-11-16       Impact factor: 3.445

2.  What is the pancreatic duct size limit for a safe duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy? A retrospective study.

Authors:  Kit-Fai Lee; Kandy Kam Cheung Wong; Eugene Yee Juen Lo; Janet Wui Cheung Kung; Hon-Ting Lok; Charing Ching Ning Chong; John Wong; Paul Bo San Lai; Kelvin Kwok Chai Ng
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2022-02-28

3.  Rate of Post-Operative Pancreatic Fistula after Robotic-Assisted Pancreaticoduodenectomy with Pancreato-Jejunostomy versus Pancreato-Gastrostomy: A Retrospective Case Matched Comparative Study.

Authors:  Marco V Marino; Adrian Kah Heng Chiow; Antonello Mirabella; Gianpaolo Vaccarella; Andrzej L Komorowski
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

Review 4.  Pancreatic outflow tract reconstruction after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials.

Authors:  Xin Xin Wang; Yu Ke Yan; Bao Long Dong; Yuan Li; Xiao Jun Yang
Journal:  World J Surg Oncol       Date:  2021-07-06       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.